Clinical Trials Logo

Clinical Trial Summary

Although there has been increasing interest in the association between cancer and cerebrovascular disease, the underlying pathophysiology of stroke in cancer patients is still not fully understood. The aim of this study is to investigate the stroke mechanisms in patients with cancer-associated stroke.


Clinical Trial Description

Patients with cryptogenic embolic stroke will be prospectively enrolled and categorized into two groups according to the presence of active cancer: cryptogenic embolic stroke with active cancer (cancer-associated stroke) vs. without active cancer (cryptogenic embolic stroke). All patients will undergo brain MRI/MRA, 12-lead electrocardiography, transthoracic and transesophageal echocardiography with injection of agitated saline, and 24-hour Holter and/or telemonitoring. Duplex ultrasonography to detect venous thrombosis of the lower extremity will also be performed in patients with a positive right-to-left shunt on echocardiography. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02212496
Study type Observational
Source Samsung Medical Center
Contact
Status Completed
Phase
Start date August 2014
Completion date March 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05403801 - STAMP+CBT mHealth for Cancer Pain N/A